References
- Schroder, H., Giacobini, E., Struble, RG., Luiten, PG., Zilles, K., Strosberg, AD. (1991) Muscahnic cholinoceptive neurons in the frontal cortex in Alzheimer's disease. Brain Res Bull. 27(5): 631-636 https://doi.org/10.1016/0361-9230(91)90038-L
- Polinsky, RJ. (1998) Clinical pharmacology of hvastigmine: a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin Ther. 20(4): 634-47 https://doi.org/10.1016/S0149-2918(98)80127-6
- Levey, AI. (1996) Muscadnic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 93(24): 13541-6 https://doi.org/10.1073/pnas.93.24.13541
-
Messer, WS Jr., Rajeswaran, WG., Cao, Y, Zhang, HJ., el- Assadi, AA., Dockery, C., Liske, J., O'Biien, J., Williams, FE., Huang, XR, Wroblewski, ME., Nagy, PI., Peseckis, SM. (2000) Design and development of selective muscahnic agonists for the treatment of Alzheimer's disease: characteri- zation of tetrahydropynmidine derivadves and development of new approaches for improved affinty and selectivity for
$M_1$ receptors. Pharm. Acta Helv. 74(2): 135-140 https://doi.org/10.1016/S0031-6865(99)00026-6 - Doody, RS. (1999) Clinical profile of donepezil in the treatment of Alzheimer's disease. Gerontotogy 45 Suppl 1:23-32 https://doi.org/10.1159/000022051
- Asthana, S., Greig, NH., Holloway, HW., Raffaele, KC., Berardi, A., Schapiro, MB., Rapoport, SL, Soncrant, TT. (1996) Clinical pharmacokinetics of arecoline in subjects with Alzheimer's disease. Clin. Pharmacol. Ther. 60(3): 276-282 https://doi.org/10.1016/S0009-9236(96)90054-5
-
Harries, MH., Samson, NA., Cilia, J., Hunter, AJ. (1998) The profile of sabcomeline (SB-202026), a functionally selective
$M_1$ receptor partial agonist, in the marmoset. Br J Pharmacol. 124(2): 409-415 https://doi.org/10.1038/sj.bjp.0701844 - Shannon, HE., Rasmussen, K., Bymaster, FP., Hart, JC., Peters, SC., Swedberg, MD., Jeppesen, L., Sheardown, MJ., Sauerberg, P, Fink-Jensen, A. (2000) Xanomeline, an M(1)/ M(4) Preferring muscannic cholineigic receptor agonist, produces antipsychodc-like activity in rats and mice. Schizophr Res. 42(3): 249-59 https://doi.org/10.1016/S0920-9964(99)00138-3
- Kim, YS., Kim, JS., Kim, SK., Heor, JH., Lee, BE., Ryu, SY. (2001) Binding affinity of some herbal extracts on the muscarinic acetylcholine receptor subtype 1 (mAChR-Ml). Kor. J. Pharmacogn. 32(3), 219-225
- Ellman, GL., Coutney, KD., Andres, V., Featherstone, RM. (1961) A new and rapid colorimetric determination acetyl- cholinesterase activity. Biochem. Pharmacol. 7: 88-95 https://doi.org/10.1016/0006-2952(61)90145-9
- Kim, JS., Choi, BW., Lee, BH., Kim, SK., Heor, JH., Kim, YS., Zee, OR, Ryu, SY. (2001) Inhibitory effect of proto- berbenne alkaloids from Copddis Rhizoma upon Acetyl- cholinesterase (AChE). the proceeding of the 50th conven- tion of Koiean Pharmaceudcal Society 2001, 04. 20, Kwangju Korea
- Schmeller, T., Latz-Bruning, B., Mink, M. (1997) Bioche-mical activities of berberine, Palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 44: 257-266 https://doi.org/10.1016/S0031-9422(96)00545-6
- Wang, W., Chen, K., Guan, Y. (1999) Effect of berbenne hydrochlohde on muscarinic receptors, Acta Pharmaceutica Sinica 34: 260-263
- Hsieh, MT., Peng, WH., Wu, CR., Wang, WH. (2000) The ameliorating effect of the cognitive-enhancing Chinese herbs on scopolamine-induced amnesia in rats. Phytother. res. 14: 375-377 https://doi.org/10.1002/1099-1573(200008)14:5<375::AID-PTR593>3.0.CO;2-5
- Peng WH, Hsieh MT, Wu CR. (1997) Effect of long term administration of berbenne on scopolamine-induced Amnesia in rats, Jpn. J. Pharmacol. 74: 261-266 https://doi.org/10.1254/jjp.74.261